Elevance Health (ELV) is trading higher as investors focus on signs that the Centers for Medicare & Medicaid Services (CMS) is giving the company more time to address alleged Medicare Advantage risk-adjustment data reporting deficiencies, reducing the perceived odds of an immediate operational hit from intermediate sanctions. The stock’s gains reflect a relief trade after March headlines flagged the possibility of a CMS action that could restrict new enrollments into certain plans.

On February 27, 2026, CMS issued a notice describing intended intermediate sanctions centered on Medicare Advantage risk-adjustment data reporting, with enrollment suspension language tied to those sanctions. Subsequent updates have pointed to an ongoing dialogue and remediation process, and separate reporting indicated CMS granted additional time to complete corrective actions, which markets are treating as a de-escalation of the near-term risk even if the matter remains unresolved.

Traders will be watching for any formal CMS documentation that changes the effective date, scope, or covered contracts under any sanction, as well as additional company filings or statements that clarify progress and potential financial exposure. Another key catalyst is how management frames Medicare Advantage membership and benefit-expense assumptions around this issue in upcoming investor communications and quarterly reporting.